D.R. Horton
DHI
Strategy
MSTR
Meritage Homes
MTH
4
KB Home
KBH
5
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.3876
- -0.0304-7.27%
Close Apr 4 16:00 ET
- 0.3050
- -0.0826-21.31%
Post 20:01 ET
2.92MMarket Cap-0.34P/E (TTM)
0.3900High0.2853Low4.87MVolume0.3147Open0.4180Pre Close1.64MTurnover74.34%Turnover RatioLossP/E (Static)7.53MShares1.870052wk High2.87P/B2.54MFloat Cap0.179052wk Low--Dividend TTM6.55MShs Float19.5600Historical High--Div YieldTTM25.05%Amplitude0.1790Historical Low0.3360Avg Price1Lot Size
Protagenic Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -54.67%1.84M | -54.67%1.84M | -79.98%1.06M | -84.70%924.6K | -68.32%2.42M | -49.16%4.06M | -49.16%4.06M | -35.33%5.27M | -31.86%6.04M | -21.82%7.65M |
| -Cash and cash equivalents | 42.75%1.84M | 42.75%1.84M | 588.57%1.06M | 321.35%924.6K | 500.60%831.78K | 498.49%1.29M | 498.49%1.29M | -3.15%153.33K | -35.21%219.44K | -71.28%138.49K |
| -Short-term investments | --0 | --0 | --0 | --0 | -78.81%1.59M | -64.34%2.77M | -64.34%2.77M | -35.96%5.12M | -31.73%5.82M | -19.25%7.51M |
| Prepaid assets | -69.17%44.4K | -69.17%44.4K | 252.53%366.9K | -49.20%444.29K | 213.82%43.99K | 152.95%144.03K | 152.95%144.03K | 2.45%104.08K | 498.16%874.67K | 8.53%14.02K |
| Total current assets | -55.17%1.88M | -55.17%1.88M | -73.54%1.42M | -80.21%1.37M | -67.80%2.47M | -47.73%4.2M | -47.73%4.2M | -34.86%5.38M | -23.26%6.92M | -21.78%7.66M |
| Non current assets | ||||||||||
| Net PPE | -40.77%73.05K | -40.77%73.05K | 52.94%85.62K | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K |
| Total non current assets | -40.77%73.05K | -40.77%73.05K | 52.94%85.62K | 6,056.05%98.19K | 6,473.35%110.76K | 6,848.28%123.33K | 6,848.28%123.33K | --55.98K | --1.6K | --1.69K |
| Total assets | -54.76%1.96M | -54.76%1.96M | -72.24%1.51M | -78.80%1.47M | -66.36%2.58M | -46.21%4.32M | -46.21%4.32M | -34.18%5.43M | -23.24%6.92M | -21.76%7.67M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -9.53%102.96K | -9.53%102.96K | -55.39%108.64K | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K |
| -accounts payable | -9.53%102.96K | -9.53%102.96K | -55.39%108.64K | -40.91%93.46K | -37.70%108.95K | -26.81%113.8K | -26.81%113.8K | 74.77%243.52K | -52.69%158.17K | -37.39%174.87K |
| Current accrued expenses | 55.10%839.8K | 55.10%839.8K | 10.35%680.69K | -39.02%581.1K | -52.38%337.15K | -12.69%541.45K | -12.69%541.45K | 48.94%616.82K | 639.89%952.91K | 40.37%707.97K |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K |
| -Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --419.76K | --394.31K | --369.13K |
| Current liabilities | 43.88%942.76K | 43.88%942.76K | -38.34%789.32K | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 131.28%1.28M | 225.08%1.51M | 59.76%1.25M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 43.88%942.76K | 43.88%942.76K | -38.34%789.32K | -55.19%674.56K | -64.37%446.1K | -41.49%655.25K | -41.49%655.25K | 46.76%1.28M | 99.02%1.51M | 16.06%1.25M |
| Shareholders'equity | ||||||||||
| Share capital | 63.29%725 | 63.29%725 | 10.83%481 | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 |
| -common stock | 63.29%725 | 63.29%725 | 10.83%481 | 3.00%447 | 2.30%444 | 2.30%444 | 2.30%444 | -74.90%434 | -74.90%434 | -74.86%434 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -17.95%-36.3M | -17.95%-36.3M | -19.41%-34.75M | -23.11%-34.11M | -22.67%-32.5M | -19.40%-30.78M | -19.40%-30.78M | -15.59%-29.1M | -14.24%-27.71M | -12.35%-26.5M |
| Paid-in capital | 8.35%37.45M | 8.35%37.45M | 5.10%35.6M | 3.93%35.03M | 3.53%34.72M | 3.56%34.56M | 3.56%34.56M | 2.11%33.87M | 2.27%33.7M | 2.56%33.54M |
| Gains losses not affecting retained earnings | -14.36%-129.85K | -14.36%-129.85K | 78.92%-130.25K | 77.81%-130.16K | 86.20%-86.77K | 83.23%-113.55K | 83.23%-113.55K | -0.43%-617.74K | -30.42%-586.46K | -57.44%-628.76K |
| Total stockholders'equity | -72.38%1.01M | -72.38%1.01M | -82.69%719.01K | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M |
| Total equity | -72.38%1.01M | -72.38%1.01M | -82.69%719.01K | -85.36%792.52K | -66.75%2.13M | -46.97%3.67M | -46.97%3.67M | -43.75%4.15M | -34.44%5.41M | -26.44%6.41M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings